FOLFOXIRI (IRINOTECAN, OXALIPLATIN, INFUSIONAL 5FU/LV) VS FOLFIRI AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC): UPDATED RESULTS AFTER 5 YEARS FOLLOW UP AND RISK-STRATIFIED ANALYSIS

EJC SUPPLEMENTS(2009)

引用 1|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要